Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cue Biopharma (CUE) Other financing activities (2017 - 2022)

Cue Biopharma's Other financing activities history spans 3 years, with the latest figure at -$1000.0 for Q4 2022.

  • For Q4 2022, Other financing activities changed N/A year-over-year to -$1000.0; the TTM value through Sep 2023 reached -$1000.0, down 100.7%, while the annual FY2022 figure was $141000.0, N/A changed from the prior year.
  • Other financing activities for Q4 2022 was -$1000.0 at Cue Biopharma, down from $142000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $509000.0 in Q2 2018 and bottomed at -$1.1 million in Q1 2018.